1.

Which Indian institute will begin the Phase II/III trial of VPM1002 vaccine for TB in June 2017?

A. Serum Institute of India Ltd
B. Panacea Biotec Ltd
C. Bharat Biotech International Ltd
D. Central Drug Research Institute
Answer» B. Panacea Biotec Ltd


Discussion

No Comment Found